IMARC Group pitches PET bottle plant DPR for investors and manufacturers

By AI, Created 8:45 PM UTC, May 19, 2026, /AGP/ – IMARC Group has released a detailed project report for a PET bottle manufacturing plant, targeting packaging investors, FMCG entrepreneurs, and lenders. The report outlines plant setup, ISBM production, financial projections, and market drivers across beverage, pharmaceutical, personal care, and food packaging.

Why it matters: - PET bottles remain a core rigid-packaging format for beverages, FMCG, pharmaceuticals, and personal care products. - Demand is being lifted by packaged water, carbonated soft drinks, juices, e-commerce, and the shift toward local supply chains. - Sustainability rules are pushing manufacturers toward recycled PET, light weighting, and compliance-ready packaging lines.

What happened: - IMARC Group released a PET Bottle Manufacturing Plant Project Report as a detailed DPR, feasibility study, and business plan for packaging investors and project developers. - The report covers plant setup using injection stretch blow moulding, from PET resin drying and preform injection to stretch blow moulding, cooling, leak testing, and palletised dispatch. - The company is also offering a sample report and a customized analyst consultation through its website.

The details: - The proposed plant is sized for annual output of 100 million to 300 million pieces. - Financial benchmarks in the report show gross profit of 25% to 35% and net profit of 10% to 15% after financing costs, depreciation, and taxes. - OpEx is led by PET resin, which accounts for 70% to 80% of total operating cost. - Utilities account for 10% to 15% of OpEx, mainly from injection moulding and compressed air use. - The report models 10-year operating costs and financial metrics including ROI, IRR, NPV, DSCR, break-even, and sensitivity tables. - The report includes product mix comparisons across water, CSD, pharma, and personal care bottles. - It also compares single-stage and two-stage ISBM equipment and cites options from Husky, Sidel, KHS, and Asian suppliers. - The report lists CapEx components including land and factory, crystalliser-dryer, injection moulding machines, stretch blow moulders, compressors, chillers, testing equipment, and palletisers. - Pre-operating costs include BIS IS 14971, FSSAI clearance, EPR registration, mould tooling, and initial resin inventory.

Between the lines: - The report frames PET bottle production as a localization play, not just a packaging business. - Proximity to resin supply and to major beverage, FMCG, and pharma customers is presented as a major cost and service advantage. - The sustainability angle is becoming a capital-allocation issue, with rPET and compliance infrastructure now part of the investment case. - The market view suggests custom mould capability is a barrier to entry in higher-margin segments such as pharma and personal care.

What’s next: - IMARC Group says the report is intended for packaging investors, FMCG companies considering backward integration, pharmaceutical firms seeking captive packaging capacity, and banks evaluating project finance. - The firm says the study can be tailored for custom investment scenarios and plant configurations. - The company is promoting additional feasibility studies across sectors including blood bags, CMC, copper tube, DAP, dog food, flexible solar panels, food processing, generic drugs, and graphite.

The bottom line: - IMARC Group is positioning PET bottle manufacturing as a scalable, compliance-sensitive, and location-dependent investment opportunity with demand tied to beverage growth and packaging localization.